BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Acetaminophen
,
rs7903146
,
MYC
,
glucose metabolic process
,
Influenza
,
Intestine
,
Alcohol
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Ras GTPase- activating protein
Summary
General Info
Curated Studies
Most Correlated Studies
Breast cancer MDA-MB-231 cells treated with RHO GTPase inhibitor DC-RC-063
GnRH-induced gene expression in primary enriched gonadotrope cells
Malignant peripheral nerve sheath tumor cells 90-8TL overexpressing SUZ12 or treated with JQ1
Malignant peripheral nerve sheath tumors treated with sirolimus (rapamycin) or PD 0325901
Anaplastic thyroid carcinoma 8505c cells expressing SOD3 and cultured in long-term
Explore Curated Studies Results
Literature
Most Relevant Literature
GAP positions catalytic H-Ras residue Q61 for GTP hydrolysis in molecular dynamics simulations, comp…
SH3 domain regulation of RhoGAP activity: Crosstalk between p120RasGAP and DLC1 RhoGAP.
Combined inhibition of Bcl-2 family members and YAP induces synthetic lethality in metastatic gastri…
Role of RASA1 in cancer: A review and update (Review).
Ras superfamily GTPase activating proteins in cancer: Potential therapeutic targets?
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients
R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Refametinib(BAY86-9766) in RAS Mutant Hepatocellular Carcinoma (HCC)
Refametinib in Combination With Sorafenib in RAS Mutant Hepatocellular Carcinoma (HCC)
KRAS Mutation and Incidence of the Colorectal Carcinoma in Martinique Between 2007 and 2009
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ